In this article, we summarized the preclinical and clinical evidence on the participation of NLRP3 activation in HSCT with an emphasis on the role of excessive inflammasome activation in the development of transplant complications including GvHD, TRM, severe infections, and disease relapse. The gene discussed is NLRP3; the disease is graft versus host disease.